Holen Sie sich die Stockscreener-App
2.38
0.42%
0.010
Handel nachbörslich:
2.37
-0.010
-0.42%
Schlusskurs vom Vortag:
$2.37
Offen:
$2.4
24-Stunden-Volumen:
77,724
Relative Volume:
0.30
Marktkapitalisierung:
$225.45M
Einnahmen:
$72.66M
Nettoeinkommen (Verlust:
$34.86M
KGV:
6.5027
EPS:
0.366
Netto-Cashflow:
$-62.91M
1W Leistung:
-4.42%
1M Leistung:
-17.07%
6M Leistung:
+15.53%
1J Leistung:
+72.46%
1-Tages-Spanne:
$2.345
$2.42
1-Wochen-Bereich:
$2.305
$2.495
52-Wochen-Spanne:
$1.37
$3.235
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN vs VRTX, REGN, MRNA, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
2.38 | 224.51M | 72.66M | 34.86M | -62.91M | 0.366 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 132.40B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.95B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 77.78B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.20B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 42.84B | 742.00K | -1.37B | -1.07B | -7.0731 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-07 | Eingeleitet | Lake Street | Buy |
| 2026-01-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2020-05-26 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2020-05-13 | Eingeleitet | Stifel | Buy |
| 2020-05-07 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-22 | Eingeleitet | ROTH Capital | Buy |
| 2020-03-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-16 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-03-29 | Eingeleitet | Oppenheimer | Outperform |
| 2016-02-01 | Fortgesetzt | Oppenheimer | Outperform |
| 2015-10-15 | Eingeleitet | FBR Capital | Outperform |
| 2015-04-23 | Fortgesetzt | Jefferies | Buy |
| 2015-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2014-02-07 | Eingeleitet | MLV & Co | Buy |
| 2009-12-28 | Bestätigt | Cantor Fitzgerald | Buy |
| 2009-07-29 | Eingeleitet | Cantor Fitzgerald | Buy |
Alle ansehen
Compugen Ltd Aktie (CGEN) Neueste Nachrichten
Compugen to host virtual event on COM701 ovaria... - Pluang
Compugen to Host Virtual KOL Event on COM701 in Ovarian Cancer & Unigen™ Platform Update on October 5, 2026 - Yahoo Finance
Compugen Stock Price Forecast. Should You Buy CGEN? - StockInvest.us
Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference - Eastern Progress
Compugen Shareholders Approve All Proposals at 2026 Annual Meeting - The Globe and Mail
All 2026 AGM proposals pass at Compugen (CGEN) - Stock Titan
Israel National Biotech Innovation Center Launches With Anat Cohen-Dayag as CEO of INBI Core - citybiz
Compugen to present at H.C. Wainwright Investme... - Pluang
A cancer treatment company will speak live Sept. 14. Compugen’s talk will be webcast. - Stock Titan
New initiative seeks $500m to commercialize Israeli life scienceGlobes - Globes - Israel Business News
Compugen (CGEN) Holds Near $2.62 as Shares Navigate Tight $2.49–$2.75 RangeBullish Pattern Stocks - careplusvn.com
All You Need to Know About Compugen (CGEN) Rating Upgrade to Buy - Yahoo Finance
Compugen (CGEN) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress
Compugen (CGEN) Reports Q2 Loss, Misses Revenue Estimates - Eastern Progress
Are Medical Stocks Lagging Compugen (CGEN) This Year? - Yahoo Finance
Compugen (CGEN) Earnings Brief: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Price Reaction: Shares Finish 1.28% Up on the DayCost Structure Review - dars.gov.et
Compugen (CGEN) Dips 2.49% to $2.35, Pressure Mounts Toward Support at $2.23Price Target - vinanet.vn
Analysts Have Just Cut Their Compugen Ltd. (NASDAQ:CGEN) Revenue Estimates By 14% - simplywall.st
CGEN Q2 2026 Earnings: Loss Narrower Than Expected as EPS Surprises PositivelyMargin Expansion Trends - vinanet.vn
Compugen Ltd. (CGEN) Slides 3.6% as Biotech Stock Approaches Key $2.29 SupportBuy Signal Reports - vinanet.vn
Compugen (NASDAQ:CGEN) Share Price Crosses Above 200-Day Moving AverageShould You Sell? - MarketBeat
Compugen (CGEN) Slips 1.8% to $2.46 as Shares Hover Near Key SupportSingle Stock ETF - Vinanet
Compugen (CGEN) Gains 4.17% to $2.50 as Immuno-Oncology Stock Shows ResilienceRange Breakout - careplusvn.com
Compugen (CGEN) Q2 2026 Earnings Call Transcript - AOL.com
Compugen (CGEN) Slips 2.9% to $2.34 as Shares Approach Key Support at $2.22RVOL Spike - careplusvn.com
Compugen Ltd. (CGEN) stock price, news, quote and history - Yahoo Finance Singapore
Compugen Ltd (CGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Compugen Ltd (CGEN) Stock News Today - TradingKey
Compugen Ltd. (CGEN) Rises 2.17% to $2.35: Biotech Stock Holds Key Support as Resistance at $2.47 LoomsMFI Overbought - vinanet.vn
Compugen: Better Runway Ahead Of MAIA - Seeking Alpha
FY2026 EPS Estimates for Compugen Raised by HC Wainwright - MarketBeat
Compugen Ltd (CGEN) (Q2 2026) Earnings Call Highlights: Advancing COM701 with Strong Cash ... By GuruFocus - Investing.com Canada
Compugen Ltd (CGEN) (Q2 2026) Earnings Call Highlights: Advancin - GuruFocus
Compugen stock maintained at Buy by H.C. Wainwright on trial data - Investing.com South Africa
H.C. Wainwright Maintains Compugen(CGEN.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Compugen Ltd. (NASDAQ:CGEN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Compugen (CGEN) Stock Holds Steady As Cash Runway Extends To 2029 - simplywall.st
CGEN Looks 54.6% Undervalued on GF Value™ - GuruFocus
Earnings call transcript: Compugen Q2 2026 revenue misses forecast as cash runway extends - Investing.com Canada
Compugen Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Compugen Q2 Earnings Call Highlights - TradingView
CGEN: Revenue doubled and clinical programs advanced, supporting a strong outlook into 2029 - TradingView
Compugen Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Q2 2026 Compugen Ltd Earnings Call Transcript - GuruFocus
Compugen (NASDAQ: CGEN) seeks votes on directors, pay policy and auditor - Stock Titan
COMPUGEN ($CGEN) Releases Q2 2026 Earnings - Quiver Quantitative
Compugen (NASDAQ:CGEN) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Compugen (NASDAQ: CGEN) reports H1 2026 results, cash runway into 2029 - Stock Titan
Compugen Reports Second Quarter 2026 Results - Yahoo Finance
Compugen announces annual shareholder meeting - Bitget
Compugen (CGEN) Edges Higher at $2.35 as Biotech Sentiment SteadiesQuote Data - careplusvn.com
Finanzdaten der Compugen Ltd-Aktie (CGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):